Literature DB >> 10664378

Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature.

A Montero1, J Romero, J A Vargas, C A Regueiro, G Sánchez-Aloz, F De Prados, A De la Torre, G Aragón.   

Abstract

Use of CSF shunt devices is a common practice in neurosurgery, and infection of the shunt is the most frequent complication. In spite of the fact that bacteria are the most widely implicated pathogens, reports of fungal infections, especially due to Candida sp., have increased in recent years. Their reported frequency ranges between 6% and 17%. Many factors have been implicated in the pathogenesis of Candida meningitis, such as broad spectrum antibiotics used in the treatment of a bacterial meningitis, steroids and indwelling bladder and intravenous catheters. The treatment of Candida meningitis still consists of systemic antifungal agents and removal of the shunt.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664378     DOI: 10.1007/s007010050009

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Microbiology and treatment of cerebrospinal fluid shunt infections in children.

Authors:  Daniel J Adams; Michael Rajnik
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

Review 2.  Fungal infections in pediatric neurosurgery.

Authors:  Adrian Caceres; Maria Luisa Avila; Marco Luis Herrera
Journal:  Childs Nerv Syst       Date:  2018-08-18       Impact factor: 1.475

Review 3.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Candida species isolated from cerebrospinal fluid.

Authors:  E Dorko; E Pilipcinec; L Tkáciková
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

5.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

6.  Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.

Authors:  Sebastian J van Hal; Damien Stark; John Harkness; Deborah Marriott
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.